Test triage and treatment for immune-related arthritis from immunotherapy
Treatments studied
Part of Bones, joints & muscles, Pain clinical trials.
This trial studies how doctors assess and manage immune-related arthritis or joint pain that happens after PD-1/PD-L1 cancer immunotherapy (sometimes with CTLA-4). It may help people get faster, more targeted care while monitoring safety.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 or older and can sign consent.
- You have cancer confirmed by tissue testing and are on anti–PD-1 or anti–PD-L1 treatment (with or without anti–CTLA-4).
- You developed treatment-related arthritis or joint pain (at least moderate, Grade 2 or higher) on or after immunotherapy.
- Your heart, lungs, and other major health problems are stable enough for study treatment (you cannot have certain serious active conditions).
- Your liver and kidney blood tests are within allowed ranges.
- You are able to follow study visits and rules (including birth control rules if applicable).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether low-dose radiation can ease joint pain and swelling caused by immunotherapy cancer treatment. It aims to help people with arthritis-like symptoms in up to three joints get relief without using more strong medications.
This trial studies a way to treat inflammation of the liver (hepatitis) caused by immune cancer medicines (anti-PD-1/PD-L1, sometimes with anti-CTLA-4) without relying on high-dose steroids. It may help reduce steroid side effects while keeping liver inflammation under control.
This study tests if a medicine called adalimumab (a type of TNF blocker) can help with new joint pain and swelling (inflammatory arthritis) caused by some immunotherapy drugs. It aims to reduce the need for high-dose steroids and improve symptoms.
This Phase 4 trial studies whether immune-modulator medicines improve symptoms and function in people with rheumatoid arthritis who have knee problems. It may also compare responses in osteoarthritis and healthy volunteers, depending on the group you fit.
This trial tests whether taking a daily antihistamine (like Claritin) and a daily aspirin alongside your immunotherapy can make the treatment work better. It's for people with solid tumors who are about to start a PD-1 or PD-L1 blocker.
This trial tests an investigational drug (DDY391) in people with moderate to severe psoriatic arthritis. The goal is to see how well it works and if it is safe, which might help reduce joint pain and skin symptoms.
Hear when a new Arthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.